Agios Pharmaceuticals Stock Forecast
NASDAQ: AGIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
AGIO analyst consensus
Consensus (10 analysts)
buy
Avg. price target
$46.00+44.11%
- Strong buy 0
- Buy 7
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 10 Wall Street analysts covering Agios Pharmaceuticals (2026-10-07), 7 rate the stock a buy or strong buy, 3 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $46.00, with a high estimate of $73.00 and a low estimate of $32.00. The average target implies upside of 44.1% from the current price of $31.92.
The spread between the highest and lowest targets is 128.1%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for AGIO.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 7 | 70% |
| Hold | 3 | 30% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $32.00 | +0.25% |
| Average target | $46.00 | +44.11% |
| High target | $73.00 | +128.70% |